V
VYGR
Voyager Therapeutics Inc
3.480
+0.040+1.16%After Hours: 3.480 0.000 0.00%19:46 08/25 EDT
OPEN/PREV CLOSE3.450/3.440
TODAY RANGE3.450-3.560
VOL307.58K
MARKET CAP214.43M
52 WEEK RANGE2.935-5.55
AVG VOL (3M)603.57K
% TURNOVER0.50%
TURNOVER--
P/E (TTM)-1.9190
% RANGE3.20%
EPS(TTM)-1.8134
P/E(FORWARD)-1.4032
P/B1.381
BVPS2.520
DIVIDEND--
P/S5.09
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP182.10M
SHARES OUTSTANDING61.62M
NEXT EARNINGS11/02-11/06
FREE FLOAT52.33M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·08/13 16:32
Voyager’s New Alzheimer’s Trial Puts VYGR on Investors’ Early Watchlist
TipRanks·08/13 11:17
Canaccord Genuity Keeps Their Buy Rating on Voyager Therapeutics (VYGR)
Simply Wall St·08/10 10:38
The Voyager Therapeutics, Inc. (NASDAQ:VYGR) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
TipRanks·08/10 10:36
Voyager Therapeutics (VYGR) Receives a Rating Update from a Top Analyst
Simply Wall St·08/08 02:40
Voyager Therapeutics (VYGR) Stock Rebounds While Cash Runway Concerns Persist
TipRanks·08/07 08:08
TD Cowen Remains a Buy on Voyager Therapeutics (VYGR)
Dow Jones·08/06 20:01
Press Release: Voyager Reports Second Quarter 2026 Financial and Operating Results
Dow Jones·08/06 20:01
*Voyager Therapeutics 2Q Loss/Shr 40c >VYGR
Seeking Alpha·07/14 15:26
How does Biogen’s novel Alzheimer’s drug compare to approved drugs
Simply Wall St·07/14 11:15
Voyager Therapeutics Drops To US$3.24, Yet Insiders May Have Sold Too Early
Same Industry
Name/Symbol
Change%
Price